| 摘要 |
<p>A method of treating an inflammatory disease in a mammal, e.g., a human, by inhibiting pro-inflammatory mediator release from basophils or mast cells in the human, by administering to the human a therapeutically effective amount of purified or recombinant platelet factor 4 (PF4), a PF4 analog, or a peptide fragment of PF4 or the analog.</p> |
